From: Urinary phthalate exposures and risk of breast cancer: the Multiethnic Cohort study
Ca | Co | WHR < 0.854 | Ca | Co | WHR ≥ 0.854 | Phet (df = 1)b | |
---|---|---|---|---|---|---|---|
116 | 475 | OR (95% CI)a | 117 | 471 | OR (95% CI)a | ||
MEHP%c | |||||||
≤ 5.49% | 35 | 147 | 1.00 | 23 | 170 | 1.00 | |
> 5.49–11.08 | 41 | 155 | 1.09 (0.66–1.81) | 47 | 153 | 2.29 (1.32–3.98) | |
> 11.08 | 40 | 173 | 0.94 (0.57–1.57) | 47 | 148 | 2.39 (1.36–4.18) | 0.02 |
P trend | 0.86 | 0.002 | |||||
Phthalic acid | |||||||
≤ 36.90 | 45 | 143 | 1.00 | 30 | 170 | 1.00 | |
> 36.90–≤ 79.76 | 37 | 161 | 0.74 (0.45–1.20) | 37 | 150 | 1.44 (0.84–2.45) | |
> 79.76 | 34 | 171 | 0.64 (0.38–1.07) | 50 | 151 | 1.98 (1.18–3.33) | 0.002 |
P trend | 0.08 | 0.01 | |||||
∑DEHP | |||||||
≤ 63.21 | 41 | 149 | 1.00 | 39 | 162 | 1.00 | |
63.21–133.05 | 38 | 160 | 0.89 (0.54–1.47) | 39 | 157 | 1.07 (0.65–1.77) | |
> 133.05 | 37 | 166 | 0.90 (0.54–1.50) | 39 | 152 | 1.16 (0.69–1.93) | 0.49 |
P trend | 0.66 | 0.59 | |||||
∑HMWP | |||||||
≤ 78.13 | 38 | 147 | 1.00 | 41 | 165 | 1.00 | |
> 78.13–149.24 | 40 | 159 | 0.99 (0.60–1.64) | 37 | 156 | 0.99 (0.60–1.63) | |
> 149.24 | 38 | 169 | 0.95 (0.57–1.58) | 39 | 150 | 1.13 (0.68–1.88) | 0.68 |
P trend | 0.85 | 0.69 | |||||
ΣLMWP | |||||||
≤ 64.0 | 42 | 154 | 1.00 | 37 | 165 | 1.00 | |
> 64.0–145.29 | 34 | 144 | 0.87 (0.53–1.45) | 39 | 162 | 1.14 (0.69–1.89) | |
> 145.29 | 40 | 177 | 0.86 (0.52–1.43) | 41 | 144 | 1.44 (0.86–2.43) | 0.17 |
P trend | 0.19 | ||||||
∑LMHMPA | |||||||
≤ 226.38 | 39 | 136 | 1.00 | 35 | 175 | 1.00 | |
> 226.38–442.34 | 38 | 157 | 0.86 (0.52–1.43) | 31 | 157 | 1.04 (0.61–1.78) | |
> 442.34 | 39 | 182 | 0.79 (0.47–1.31) | 51 | 139 | 2.01 (1.22–3.32) | 0.01 |
P trend | 0.35 | 0.01 |